CN111187186B - Intermediate SA-01 of active natural product Solanoeclepin A and preparation method thereof - Google Patents

Intermediate SA-01 of active natural product Solanoeclepin A and preparation method thereof Download PDF

Info

Publication number
CN111187186B
CN111187186B CN202010035466.0A CN202010035466A CN111187186B CN 111187186 B CN111187186 B CN 111187186B CN 202010035466 A CN202010035466 A CN 202010035466A CN 111187186 B CN111187186 B CN 111187186B
Authority
CN
China
Prior art keywords
compound
reaction
preparation
natural product
solanoeclepin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN202010035466.0A
Other languages
Chinese (zh)
Other versions
CN111187186A (en
Inventor
孙茂
晏晨
张云东
张甜
张卫青
王天元
梁伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anshun people's hospital
Original Assignee
Anshun people's hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anshun people's hospital filed Critical Anshun people's hospital
Priority to CN202010035466.0A priority Critical patent/CN111187186B/en
Publication of CN111187186A publication Critical patent/CN111187186A/en
Application granted granted Critical
Publication of CN111187186B publication Critical patent/CN111187186B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00Preparation of sulfones; Preparation of sulfoxides
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N41/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom
    • A01N41/02Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom containing a sulfur-to-oxygen double bond
    • A01N41/10Sulfones; Sulfoxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00Preparation of sulfones; Preparation of sulfoxides
    • C07C315/04Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/16Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/22Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/04Systems containing only non-condensed rings with a four-membered ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to a preparation method of a GE ring system intermediate SA-01 of a natural product Solanoeclepin A with extremely strong induction activity in a hatching process of potato cyst nematodes, which comprises the following steps: uses geraniol acetate as a starting material to quickly synthesize SA-03 according to a method reported by a literature, wherein the SA-03 generates SN through reacting with sodium phenylsulfinate2After the substitution reaction, removing acetyl protection by potassium carbonate to obtain a compound SA-05; the compound SA-05 is subjected to active manganese dioxide oxidation, HWE reaction to prolong a carbon chain and excessive DIBAL-H reduction to obtain a diallyl alcohol compound SA-08; and the compound SA-08 is subjected to chemoselective asymmetric cyclopropanation reaction induced by a Charette ligand and asymmetric Staudinger cycloaddition reaction induced by substrate chirality to finally complete the synthesis of the intermediate compound SA-01. The preparation method is novel, the raw materials are easy to obtain, the operation is simple, the yield of the product is high, and the mass preparation is easy.

Description

Intermediate SA-01 of active natural product Solanoeclepin A and preparation method thereof
Technical Field
The invention relates to an intermediate (GE ring system) SA-01 of a natural product Solanoeclepin A with extremely strong induction activity in a hatching process of potato cyst nematodes (PCN; Globodera rostochiensis and G.pallida) and a preparation method thereof.
Background
The natural product Solanoeclepin a (fig. 13) was isolated from potato roots of the solanaceae family by the dutch scientist Mulder in 1986 and has a very unique high tensile core skeleton (DEFG ring system) in its structure, while the chiral cyclopropane, cyclobutane and side chain functional moieties in the intermediate compound SA-01 have structures consistent with their GE ring systems and are also important functional fragments of the natural product exhibiting biological activity (CN 105326825 a, against lung cancer metastasis). In addition, the natural product is found to have extremely strong induction activity (0.3 g/hectare of land) on the hatching process of potato cyst nematode (PCN; Globodera rostochiensis and G.pallida) which causes a large reduction in yield of potatoes. Therefore, based on the unique chemical structure, the biological activity with great application value and limited sources of solaoeclepin A (figure 13), the method realizes the mass preparation of the key part (intermediate SA-01) in the structure by developing a novel synthesis methodology and an efficient synthesis strategy, is an important basis for breaking through the source limitation of the natural product and realizing further biological activity research, and has important significance for searching novel anti-lung cancer metastasis and developing natural pesticides.
Disclosure of Invention
The invention aims to: a natural product Solanoeclepin A intermediate (GE ring system) SA-01 with extremely strong induction activity (0.3 g/hectare land) on the hatching process of Potato Cyst Nematodes (PCN), Globodera rostochiensis and G.pallida and a preparation method thereof are important synthetic raw materials of the active natural product, have important application value on developing further drug discovery, and are very economical and simple.
The invention is realized by the following steps:
an active natural product Solanoeclepin A intermediate SA-01, the compound has the structure shown in formula (1)
Figure GDA0003340110730000011
In the formula, R1Is an alkyl protecting group such as benzyl, p-methoxybenzyl, or a silyl ether protecting group such as TBDPS, TBS, TIPS, TMS, or an ester group such as acetate, benzoate, sulfonate; r2Is H or alkyl or halogen or hydroxy; x is O or CH2. The intermediate SA-01 has strong induction activity on the hatching process of potato cyst nematodes: 0.3 g/ha of land.
The preparation method of the intermediate SA-01 of the active natural product Solanoeclepin A is characterized by comprising the following steps:
firstly, geraniol acetate is taken as a starting material, and the starting material is Mori, K. reported in the literature; nakazono, Y.Liebigs Ann.chem.1988,167, large-scale preparation of compound SA-03;
A. the compound SA-03 and sodium phenylsulfinate undergo substitution reaction under the catalysis of NaI to obtain a compound SA-04;
performing ester exchange on SA-04 under the conditions of potassium carbonate and methanol to remove acetyl protecting groups to obtain a compound SA-05;
C. the compound SA-05 is prepared by oxidizing allyl alcohol into unsaturated aldehyde by active manganese dioxide, reacting with HWE to prolong the carbon chain to obtain a compound SA-07, and reducing by a certain amount of DIBAL-H to obtain a diallyl alcohol compound SA-08;
SA-08 produces chemoselective asymmetric cyclopropanation reaction under the catalytic action of a Charette chiral ligand to obtain a compound SA-09;
SA-09 is protected with an alkyl protecting group, such as benzyl, p-methoxybenzyl, or a silyl ether protecting group, such as TBDPS, TBS, TIPS, TMS, or an ester group, such as acetate, benzoate, sulfonate, to prepare compound SA-10;
SA-10 adopts Staudinger ketene cycloaddition reaction to construct cyclobutanone structure to obtain a compound SA-11;
g, performing Zn/Cu reduction dechlorination on the SA-11 to obtain a compound SA-12;
H. converting cyclobutanone into a terminal double-bond compound SA-13 by a compound SA-12 through a Wittig reaction;
I. removing alpha hydrogen of sulfuryl from the compound SA-13 by n-butyl lithium, and introducing R through oxidation reaction or halogenation reaction or alkylation reaction2And finally obtaining the compound SA-01.
The synthetic route of the invention is as follows:
Figure GDA0003340110730000031
a.PhSO2Na,NaI,DMF,80℃;b.K2CO3,MeOH,rt;c.MnO2,DCM;d.NaH,(EtO)2P(O)CH2CO2Et,THF,0℃-r.t.;e.DIBAL-H,-78℃;f.ligand A,CH2I2,Et2Zn,DME/DCM,-20℃;g.base,R1X,DMF(X=Cl or Br);h.Zn/Cu,POCl3,CCl3COCl,Et2O,rt to reflux;i.Zn/Cu,NH4Cl,MeOH,50℃;j.Ph3PCH3Br,n-BuLi,THF,-78℃ to rt;k.n-BuLi,R2X,THF,-78℃(X=Cl or Br).
wherein R is1Is an alkyl protecting group such as benzyl, p-methoxybenzyl, or a silyl ether protecting group such as TBDPS, TBS, TIPS, TMS, or an ester group such as acetate, benzoate, sulfonate; r2Is H or alkyl or halogen or hydroxy; x is O or CH2
By adopting the technical scheme, the compound SA-03 is prepared in a large quantity by taking geraniol acetate as a starting material according to the literature report (Mori, K.; Nakazono, Y.LiebigsAnn. chem.1988, 167.); the compound SA-03 and sodium phenylsulfinate undergo substitution reaction under the catalysis of NaI to obtain a compound SA-04; then ester exchange is carried out under the conditions of potassium carbonate and methanol to remove acetyl protecting group, thus obtaining a compound SA-05; the compound SA-07 is obtained by oxidizing allyl alcohol into unsaturated aldehyde by active manganese dioxide and extending carbon chain through HWE reaction; reducing by a certain amount of DIBAL-H to obtain a bisallyl alcohol compound SA-08; the compound SA-08 has chemoselective asymmetric cyclopropanation reaction under the catalytic action of a Charette chiral ligand to obtain a compound SA-09; compounds SA-09 using alkyl-protecting groups, e.g. benzylProtecting group, p-methoxybenzyl, or silyl ether protecting group, such as TBDPS, TBS, TIPS, TMS, or ester group, such as acetate, benzoate, sulfonate, to prepare compound SA-10; constructing a cyclobutanone structure by adopting Staudinger ketene cycloaddition reaction to obtain a compound SA-11; SA-10 is subjected to Zn/Cu reduction dechlorination to obtain a compound SA-12; converting cyclobutanone into a terminal double-bond compound SA-13 by a compound SA-12 through a Wittig reaction; then n-butyl lithium is used for removing alpha hydrogen of sulfuryl, and then R is introduced through oxidation reaction or halogenation reaction or alkylation reaction2And finally obtaining the compound SA-01.
The compound SA-01 is a key part of a natural product Solanoeclepin A showing bioactivity, is an important basis for breaking through the source limitation of the natural product and realizing further bioactivity research, and has important significance for searching novel anti-lung cancer metastasis and developing natural pesticides. Meanwhile, the chemical reaction involved in the invention has the advantages of simple and easy operation, cheap and easily available raw material synthesis, environmental protection and no use of expensive metal catalysts.
Drawings
FIGS. 1-12 are NMR spectra of compounds of examples of the invention;
FIG. 13 shows the structural formula of Solanoeclepin A, a natural product.
Detailed Description
The invention is further described below by way of examples.
An active natural product Solanoeclepin A (figure 13) intermediate SA-01, the compound has a structure shown as formula (1)
Figure GDA0003340110730000041
In the formula, R1Is an alkyl protecting group such as benzyl, p-methoxybenzyl, or a silyl ether protecting group such as TBDPS, TBS, TIPS, TMS, or an ester group such as acetate, benzoate, sulfonate; r2Is H or alkyl or halogen or hydroxy; x is O or CH2. The intermediate SA-01 has strong induction activity on hatching process of potato cyst nematode: 0.3 g/ha of land.
The synthetic route of the invention is as follows:
Figure GDA0003340110730000051
1. synthesis of Compound SA-04:
Figure GDA0003340110730000052
the compound SA-03 (known compound reported in literature, see Mori, K.; Nakazono, Y. Liebigs Ann. chem.1988,167.) (39.6g,121.4mmol) was dissolved in DMF (200mL), and NaI (36.4g,242.8mmol), PhSO, were added sequentially at room temperature2Na (75.5g,459.9mmol) was added and the reaction stirred at 80 ℃ for 12 h. H2Quench the reaction with O (300mL), extract with EtOAc (150mL x 3), combine the organic phases, wash with saturated NaCl (100mL x 3), Na2SO4Drying, rotary removal of the solvent under reduced pressure, and column chromatography on silica gel (petroleum ether/EtOAc,8:1) afforded SA-04 as a pale yellow oil (28.7g, 80%). Rf=0.3(petroleum ether/EtOAc,8:1);1H NMR(400MHz CDCl3)δ7.89–7.87(m,2H),7.66–7.62(m,1H),7.57–7.53(m,2H),5.82–5.25(m,1H),4.52(d,J=6.9Hz,1H),3.04–3.00(m,2H),2.10–2.06(m,2H),2.01(s,3H),1.85–1.80(m,2H),1.60(s,3H);13C NMR(125MHz,CDCl3)δ170.89,139.57,139.21,133.67,133.67,129.29,129.29,128.00,128.00,120.31,60.97,55.39,37.59,20.93,20.39,15.99;HRMS(ESI)m/z:calculated for C16H23O5S[M+H]+327.4162,found 327.4158.
2. Synthesis of Compound SA-05:
Figure GDA0003340110730000061
compound SA-04(28.7g,97.1mmol) is dissolved in MeOH (150mL) and K is added at room temperature2CO3(7.3g,52.8mmol), reaction at room temperatureThe reaction was stirred for 2 h. H2The reaction was quenched with O (200mL), most of the MeOH removed under reduced pressure, extracted with EtOAc (150mL x 3), the combined organic phases washed with saturated NaCl (100mL x 3), Na2SO4Drying, rotary removal of the solvent under reduced pressure, and column chromatography on silica gel (petroleum ether/EtOAc,1:1) afforded SA-05(24.4g, 99%) as a colorless oil. Rf=0.3(petroleum ether/EtOAc,1:1);1H NMR(400MHz CDCl3)δ7.84–7.82(m,2H),7.61–7.57(m,1H),7.52–7.48(m,2H),5.29–5.26(m,1H),4.03(d,J=6.9Hz,1H),3.02–2.98(m,2H),2.27(s,1H),2.02–1.98(m,2H),1.80–1.74(m,2H),1.50(s,3H);13C NMR(125MHz,CDCl3)δ139.02,136.43,136.36,133.72,129.30,127.94,125.51,58.90,58.87,55.36,37.53,20.43,15.77;HRMS(ESI)m/z:calculated for C13H19O3S[M+H]+255.3534,found 255.3534.
3. Synthesis of Compound SA-08:
Figure GDA0003340110730000062
compound SA-05(24.4g,96.1mmol) is dissolved in CH2Cl2(200mL), MnO was added to the solution in portions at room temperature2(53.0g,124.9mmol) the reaction mixture was stirred at room temperature for a further 2h, filtered off with suction over celite under reduced pressure and the solvent was removed by rotation. The crude product was carried on to the next reaction without purification.
Triethyl phosphonoacetate (17.2mL,288.3mmol) is slowly added dropwise to a THF (200mL) suspension of NaH (11.5g,288.3mmol, 60% oil suspension) at 0 deg.C, after the reaction system stops generating gas, a THF (50mL) solution of the crude product from the previous step is slowly added dropwise to the reaction system, and the reaction is continued for 1h at room temperature. Saturated NH4The reaction was quenched with Cl (100mL), the solvent was spun off under reduced pressure to remove most of the THF, extracted with EtOAc (150 mL. times.3), and the organic phases combined, Na2SO4Drying, removing solvent under reduced pressure, adding CH2Cl2(50mL) was dissolved, filtered through silica gel with suction under reduced pressure, the silica gel was washed with (petroleum ether/EtOAc,3:1) and the solvent was removed by vortexing under reduced pressure to give a pale yellow oil.
The crude product of the previous step is dissolved in anhydrous CH2Cl2(300mL) DIBAL-H (120.1mL,240.3mmol,2M in CH) was slowly added dropwise at-78 deg.C2Cl2) The reaction mixture was allowed to continue at-78 ℃ for 30 min. The reaction was quenched with saturated Rochelle salt (300mL), warmed to room temperature, and stirred for 5 h. CH (CH)2Cl2(150 mL. times.3) extraction, combine the organic phases, Na2SO4Drying, rotary removal of the solvent under reduced pressure, and column chromatography on silica gel (petroleum ether/EtOAc,2:1) afforded SA-08(21.8g, 81%) as a colorless oil. Rf=0.3(petroleum ether/EtOAc,2:1);1H NMR(400MHz CDCl3)δ7.82–7.80(m,2H),7.59–7.56(m,1H),7.50–7.47(m,2H),6.32(dd,J=15.1,11.9Hz,1H),5.69–5.60(m,2H),4.07(d,J=5.8Hz,2H),2.98–2.94(m,2H),2.28(s,1H),2.03(m,2H),1.79–1.73(m,2H),1.57(s,3H);13C NMR(125MHz,CDCl3)δ139.06,136.37,133.72,130.90,129.31,129.31,127.96,127.96,127.18,125.62,63.23,55.39,37.86,20.56,16.12;HRMS(ESI)m/z:calculated for C15H21O3S[M+H]+281.3907,found 281.3905.
4. Synthesis of Compound SA-10:
Figure GDA0003340110730000071
et at-20 deg.C2Zn (55.6mL,55.6mmol,1.0M in hexane) was added to anhydrous CH2Cl2(100mL), CH was slowly added dropwise2I2(8.96mL,111.1mmol), DME (5.8mL,55.6mmol) to give a clear cyclopropanating reagent solution. At-20 ℃ it was then slowly added dropwise to the mixture of SA-08(5.2g,18.5mmol) and ligand A[3](6.0g,22.2mmol) of CH2Cl2(50mL) and the reaction was continued at-20 ℃ for 2 h. Saturated NH4Cl (80mL) quench the reaction, CH2Cl2(50 mL. times.3) extraction, combine the organic phases, Na2SO4Drying, and rotary removing the solvent under reduced pressure to obtain a mixture of the monocyclopropanation and the dicyclopropylation, and directly carrying out the next reaction without purification.
A solution of the crude product from the previous step in anhydrous DMF (20mL) was slowly added dropwise to a suspension of NaH (1.4g,57.1mmol, 60% oil suspension) in DMF (20mL) at 0 ℃ to generate a large amount of bubbles, and after 0.5h of reaction continued at 0 ℃, benzyl bromide (4.52mL,38.08mmol) was slowly added dropwise to the reaction system and reaction continued at room temperature for 3 h. Adding saturated NH4Cl (80mL) quench reaction, Et2O (100mL x 3) extraction, saturated NaCl (100mL x 3) wash, Na2SO4Drying, rotary removal of the solvent under reduced pressure, and column chromatography on silica gel (petroleum ether/EtOAc,6:1) afforded SA-10(5.31g, 75%) as a colorless oil. Rf=0.3(petroleum ether/EtOAc,6:1);1H NMR(400MHz CDCl3)δ7.91–7.89(m,2H),7.64–7.63(m,1H),7.57–7.54(m,2H),7.34–7.24(m,5H),4.58–4.52(m,3H),3.38–3.35(m,2H),3.04–3.00(m,2H),2.00(m,2H),1.84–1.76(m,2H),1.62(s,3H),1.30(m,1H),1.03(m,1H),0.65(m,1H),0.52(m,1H);13C NMR(125MHz,CDCl3)δ139.30,138.57,133.59,132.23,129.26,129.26,128.88,128.36,128.36,128.04,128.04,127.76,127.63,127.53,73.50,72.46,55.54,37.60,20.70,20.22,16.23,15.98,12.19;HRMS(ESI)m/z:calculated for C23H29O3S[M+H]+385.5402,found 385.5402.
5. Synthesis of Compound SA-12:
Figure GDA0003340110730000081
compound SA-10(49.5g,129.0mmol) was dissolved in anhydrous Et2To O (1500mL), Zn/Cu couple (17.0g,258.0mmol) was added, and Cl was added3CCOCl (22.0mL,193.0mmol) and POCl3(18.0mL,193.0mmol) in anhydrous Et2O (1500mL), was added slowly dropwise (4h) to the reaction system and refluxed at 37 ℃ for 12 h. Adding saturated NaHCO3The reaction was quenched (1000mL), suction filtered through celite under reduced pressure, and the filtrate was washed with saturated sodium chloride (800 mL. times.3), Na2SO4Drying, and removing the solvent under reduced pressure. The crude product is dissolved in saturated NH4A solution of Zn/Cu cobble (25.0g,385.0mmol) in Cl in methanol (500mL) was added and the mixture was heated to 50 deg.CAfter 0.5h of reaction. Suction filtration over silica gel, concentration of the filtrate, addition of EtOAc (1500mL) and water (500mL) to the concentrated crude product and continued washing of the organic phase with saturated sodium chloride (3X 500mL), Na2SO4Drying, rotary removal of the solvent under reduced pressure, and column chromatography on silica gel (petroleum ether/EtOAc,4:1) afforded SA-11(33.0g, 65%) as a colorless oil.
At-78 ℃ to PPh3CH3Br (33.5g,94.0mmol) in THF (200mL) was slowly added dropwise n-BuLi (44.0mL,70.0mmol,1.6M in THF), and after stirring the reaction for 30min, a solution of compound SA-11(10.0g,24.0mmol) in THF (100mL) was added and allowed to spontaneously warm to room temperature for 4 h. Adding saturated NH4The reaction was quenched with Cl (300mL), concentrated to remove most of the THF, extracted with EtOAc (500mL x 3), washed with saturated NaCl (500mL x 3), Na2SO4Drying, rotary removal of the solvent under reduced pressure, and column chromatography on silica gel (petroleum ether/EtOAc,10:1) afforded SA-12 as a colorless oil (6.6g, 65%). Rf=0.3(petroleum ether/EtOAc,8:1);1H NMR(400MHz CDCl3)δ7.91–7.78(m,2H),7.65–7.61(m,1H),7.56–7.51(m,2H),7.33–7.24(m,5H),4.90(s,1H),4.75(s,1H),4.51(m,2H),3.36–3.23(m,2H),3.05(m,2H),2.30–2.12(m,2H),1.88(m,1H),1.72–1.65(m,2H),1.55–1.42(m,2H),1.06(s,3H),0.75(m,1H),0.59(m,1H),0.47(m,2H);13C NMR(125MHz,CDCl3)δ149.28,139.31,138.67,133.64,129.28,129.22,129.19,129.13,129.11,128.35,128.03,127.52,127.47,105.26,73.97,72.60,56.95,56.72,42.63,41.39,38.22,19.75,18.58,16.06,15.74,9.44;HRMS(ESI)m/z:calculated for C26H33O3S[M+H]+425.6041,found 425.6042.
6. Synthesis of Compound SA-01:
Figure GDA0003340110730000082
compound SA-12(20.0g,50.0mmol) was dissolved in anhydrous THF (2000mL), n-BuLi (40.0mL,60.0mmol,1.6M in THF) was slowly added dropwise thereto at-78 deg.C, the reaction was continued for 30min with stirring, allyl bromide (4.8mL,60.0mmol) was added thereto, and the mixture was allowed to naturally warm to room temperature,the reaction was stirred for an additional 6 h. Adding saturated NH4The reaction was quenched with Cl (300mL), concentrated to remove most of the THF, extracted with EtOAc (300mL x 3), washed with saturated NaCl (500mL x 3), Na2SO4Drying, rotary removal of the solvent under reduced pressure, and column chromatography on silica gel (petroleum ether/EtOAc,15:1) afforded SA-01(19.2g, 88%) as a colorless oil. Rf=0.4(petroleum ether/EtOAc,10:1);1H NMR(400MHz CDCl3)δ7.89–7.87(m,2H),7.64–7.61(m,1H),7.56–7.52(m,2H),7.34–7.26(m,5H),5.71(m,1H),5.07(s,1H),5.04(m,1H),4.90(d,J=2.2Hz,1H),4.75(d,J=2.2Hz,1H),4.51(m,2H),3.38–3.21(m,2H),2.95(m,1H),2.61(m,1H),2.41–2.10(m,3H),1.88–1.75(m,2H),1.65–1.41(m,3H),1.05(s,3H),0.77(m,1H),0.59(m,1H),0.48(m,2H);13C NMR(125MHz,CDCl3)δ149.45,138.71,138.17,138.12,133.64,133.34,129.17,129.16,128.83,128.80,128.34,127.57,127.52,127.49,127.45,118.44,118.41,105.18,105.14,74.00,73.98,72.56,72.54,64.30,64.26,56.88,56.83,42.57,39.54,39.46,38.28,38.27,32.27,32.20,22.82,22.76,19.72,19.68,16.10,16.09,15.84,15.81,9.53,9.45;HRMS(ESI)m/z:calculated for C29H37O3S[M+H]+465.6681,found 465.6681。
Through inspection, the structures of chiral cyclopropane, cyclobutane and side chain functional group parts in the intermediate compound SA-01 synthesized by the invention are consistent with the GE ring system, and are consistent with the reported experimental results: is also an important functional group fragment of the natural product showing biological activity (CN 105326825A, resisting lung cancer metastasis), and the natural product has extremely strong induction activity (0.3 g/ha land) on the hatching process of potato cyst nematode (PCN; Globodera rostochiensis and G.pallida) causing mass reduction of potatoes.
The preparation method is novel, raw materials are easy to obtain, the operation is simple, the yield of the product is high, the large-scale preparation is easy, and the application of the product as a drug intermediate for resisting potato cyst nematodes can be expected.

Claims (1)

1. A preparation method of an intermediate SA-01 of an active natural product Solanoeclepin A is characterized by comprising the following steps: the method comprises the following steps: from the known compound SA-03 the following procedure was followed,
A. the compound SA-03 and sodium phenylsulfinate undergo substitution reaction under the catalysis of NaI to obtain a compound SA-04;
B. then ester exchange is carried out under the conditions of potassium carbonate and methanol to remove acetyl protecting group, thus obtaining a compound SA-05;
C. oxidizing the compound SA-05 with active manganese dioxide to obtain an unsaturated aldehyde compound SA-06, then, extending a carbon chain through HWE reaction to obtain a compound SA-07, and finally, reducing with excessive DIBAL-H to obtain a bis-allyl alcohol compound SA-08;
D. the compound SA-08 has chemoselective asymmetric cyclopropanation reaction under the catalytic action of a Charette chiral ligand to obtain a compound SA-09;
E. compound SA-09 protected with benzyl to prepare compound SA-10;
F. constructing a cyclobutanone structure by adopting Staudinger ketene cycloaddition reaction to obtain a compound SA-11;
g, reducing and dechlorinating SA-11 by adopting a zinc-copper reagent to obtain a compound SA-12;
H. converting cyclobutanone into a terminal double-bond compound SA-13 by a compound SA-12 through a Wittig reaction;
I. then n-butyl lithium is used for removing alpha hydrogen of sulfuryl, and then R is introduced by reacting with allyl bromide2Group, finally to obtain compound SA-01, wherein R1Is benzyl, R2Is allyl;
Figure FDA0003340110720000011
CN202010035466.0A 2020-01-14 2020-01-14 Intermediate SA-01 of active natural product Solanoeclepin A and preparation method thereof Expired - Fee Related CN111187186B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010035466.0A CN111187186B (en) 2020-01-14 2020-01-14 Intermediate SA-01 of active natural product Solanoeclepin A and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010035466.0A CN111187186B (en) 2020-01-14 2020-01-14 Intermediate SA-01 of active natural product Solanoeclepin A and preparation method thereof

Publications (2)

Publication Number Publication Date
CN111187186A CN111187186A (en) 2020-05-22
CN111187186B true CN111187186B (en) 2022-02-22

Family

ID=70703765

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010035466.0A Expired - Fee Related CN111187186B (en) 2020-01-14 2020-01-14 Intermediate SA-01 of active natural product Solanoeclepin A and preparation method thereof

Country Status (1)

Country Link
CN (1) CN111187186B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103788078A (en) * 2014-02-26 2014-05-14 中国科学院昆明植物研究所 Tetranortriterpenoid as well as preparation method and applications thereof
CN105326825A (en) * 2015-11-15 2016-02-17 淄博齐鼎立专利信息咨询有限公司 Application of Solanoeclepin A in preparing lung cancer metastasis resisting medicine

Also Published As

Publication number Publication date
CN111187186A (en) 2020-05-22

Similar Documents

Publication Publication Date Title
CN111718228B (en) Method for synthesizing carboxylic acid for prolonging two carbon chains by one step from olefin
CA2710725A1 (en) Protected aldehydes for use as intermediates in chemical syntheses, and processes for their preparation
CN111423304B (en) Synthetic method of 1,1-difluoroolefin compound
CN111187186B (en) Intermediate SA-01 of active natural product Solanoeclepin A and preparation method thereof
TWI628185B (en) Intermediates for synthesizing treprostinil and preparation method thereof as well as the preparation method of treprostinil thereby
CN115215814A (en) Synthetic method of isoxazolidine compounds
CN109369678B (en) Synthetic method of natural product isomer (-) -6-epi-Poranteridine
CN108727323B (en) Method for catalytically synthesizing trifluoromethyl substituted homoisoflavone compound by using N-heterocyclic carbene
CN110015946B (en) Preparation method of 1, 5-diaryl-4-pentene-1-alcohol compound
CN113234087A (en) Solanoeclepin A structural analogue SMS-01 of tetranortriterpenes natural product
CN109761842B (en) Synthesis method of alpha-F-beta-NHAc-carbonyl compound
CN115353437B (en) Synthesis method of cis-2-methyl-7-octadecene and cis-7, 8-epoxy-2-methyl octadecane
CN108358761B (en) Salvianolic acid A intermediate and preparation method thereof
US7754891B2 (en) 5,5′-Position linked 1,1′-biphenyl axial chiral ligand and method for preparing the same
CN104418707B (en) A kind of method of asymmetric synthesis of natural products Bakuchiol and its enantiomer
CN111662287B (en) Preparation of 5-tert-butyl-4-ethyl-3-methyl-dihydro-3H-imidazopyridine- (4H) -diformyl ester
CN110128303B (en) Method for synthesizing musk extract (2R,5R) -Musclide-A1
JP4635251B2 (en) Organic bismuth compound and process for producing the same
CN109665967B (en) Ligand for asymmetric epoxidation reaction of indene compounds and preparation method and application thereof
JP4759722B2 (en) Process for producing aromatic carboxylic acid ester having a substituent
KR100195888B1 (en) Process for producing d,l-3-methyl-cyclopentadecan-1-one
CN116535342A (en) Preparation method of sulfur ylide compound
EP0022482B1 (en) Process for preparing 4-hydroxy-3-methyl-2-(2-propynyl)-2-cyclopentenolone; a gamma-diketone compound and substituted acetonedicarboxylic esters
CN116041245A (en) Preparation method of 4- (difluoromethoxy) -1H-indole-2-carboxylic acid
CA1338868C (en) Process for the production of cis-hydroxy trans-phenoxycyclopentylamines

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20220222

CF01 Termination of patent right due to non-payment of annual fee